Management of Bleeding After IUD Insertion

Initial Diagnostic Evaluation

The American College of Obstetricians and Gynecologists recommends performing a pregnancy test to exclude pregnancy, including ectopic pregnancy, which carries significant morbidity and mortality risk 2
A speculum examination should be conducted to verify IUD strings are visible and the device is properly positioned, as displacement is a common cause of abnormal bleeding 2
Screening for sexually transmitted infections, such as gonorrhea and chlamydia, is recommended, particularly if risk factors are present, as STDs can manifest as abnormal bleeding 2
Evaluation for new uterine pathology, such as polyps, fibroids, or endometrial abnormalities, through pelvic ultrasound is recommended if clinically indicated, especially in women who have been using the IUD for months and develop new-onset heavy bleeding 1, 2

The Centers for Disease Control and Prevention recommends providing reassurance that unscheduled spotting, light bleeding, heavy or prolonged bleeding is common during the first 3-6 months of Cu-IUD use, is generally not harmful, and decreases with continued use 1
Enhanced counseling about expected bleeding patterns reduces method discontinuation, according to the Centers for Disease Control and Prevention 1

The American College of Obstetricians and Gynecologists recommends NSAIDs, such as mefenamic acid, naproxen, or ibuprofen, for 5-7 days during bleeding episodes as first-line therapy, which reduces menstrual blood loss by 20-60% 1, 2
Tranexamic acid can be added for 5 days during menstruation for Cu-IUD users with persistent heavy bleeding, which reduces blood loss by 40-60%, according to the American College of Obstetricians and Gynecologists 2, 3

The American College of Obstetricians and Gynecologists recommends removing the IUD when medical management fails and the patient finds bleeding unacceptable 1, 2
The IUD should be removed if underlying pathology is identified that cannot be adequately treated with the IUD in place, according to the American College of Obstetricians and Gynecologists 2

The American College of Obstetricians and Gynecologists advises against dismissing bleeding without ruling out pregnancy, infection, or structural pathology 4
Evaluation should not be delayed beyond 3-6 months if bleeding persists, as this warrants reassessment for IUD displacement, infection, pregnancy, or new pathologic conditions, according to the Centers for Disease Control and Prevention 1, 2

The Centers for Disease Control and Prevention recommends that no routine follow-up visit is required, but advises women to return at any time to discuss side effects, concerns, or if they want to change methods 1, 4